Paul R Michl

Array ( [id] => 6876786 [patent_doc_number] => 20010006939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-05 [patent_title] => 'SECRETORY LEUKOCYTE PROTEASE INHIBITOR DRY POWDER PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => new-utility [patent_app_number] => 08/943759 [patent_app_country] => US [patent_app_date] => 1997-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17687 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20010006939.pdf [firstpage_image] =>[orig_patent_app_number] => 08943759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4115091 [patent_doc_number] => 06046166 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders' [patent_app_type] => 1 [patent_app_number] => 8/940096 [patent_app_country] => US [patent_app_date] => 1997-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 23 [patent_no_of_words] => 54900 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 542 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/046/06046166.pdf [firstpage_image] =>[orig_patent_app_number] => 940096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4218861 [patent_doc_number] => 06111069 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site' [patent_app_type] => 1 [patent_app_number] => 8/933843 [patent_app_country] => US [patent_app_date] => 1997-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18906 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/111/06111069.pdf [firstpage_image] =>[orig_patent_app_number] => 933843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3931495 [patent_doc_number] => 05928896 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site' [patent_app_type] => 1 [patent_app_number] => 8/934222 [patent_app_country] => US [patent_app_date] => 1997-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18508 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/928/05928896.pdf [firstpage_image] =>[orig_patent_app_number] => 934222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3981573 [patent_doc_number] => 05948887 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site' [patent_app_type] => 1 [patent_app_number] => 8/933402 [patent_app_country] => US [patent_app_date] => 1997-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18510 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948887.pdf [firstpage_image] =>[orig_patent_app_number] => 933402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4100168 [patent_doc_number] => 06100044 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site' [patent_app_type] => 1 [patent_app_number] => 8/934224 [patent_app_country] => US [patent_app_date] => 1997-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18515 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100044.pdf [firstpage_image] =>[orig_patent_app_number] => 934224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4134710 [patent_doc_number] => 06147189 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site' [patent_app_type] => 1 [patent_app_number] => 8/934223 [patent_app_country] => US [patent_app_date] => 1997-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18908 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/147/06147189.pdf [firstpage_image] =>[orig_patent_app_number] => 934223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1231583 [patent_doc_number] => 06693074 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-17 [patent_title] => 'Cystine depleted glycoprotein hormones' [patent_app_type] => B1 [patent_app_number] => 08/933693 [patent_app_country] => US [patent_app_date] => 1997-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 7734 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 224 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/693/06693074.pdf [firstpage_image] =>[orig_patent_app_number] => 08933693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3936946 [patent_doc_number] => 05972887 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Treatment of intestinal epithelial cell malfunctions with Hepatocyte Growth Factor' [patent_app_type] => 1 [patent_app_number] => 8/932391 [patent_app_country] => US [patent_app_date] => 1997-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 3585 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972887.pdf [firstpage_image] =>[orig_patent_app_number] => 932391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3787234 [patent_doc_number] => 05840696 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ)' [patent_app_type] => 1 [patent_app_number] => 8/927328 [patent_app_country] => US [patent_app_date] => 1997-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 9331 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840696.pdf [firstpage_image] =>[orig_patent_app_number] => 927328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1479453 [patent_doc_number] => 06451975 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Protein composition and process for isolating a protein composition from a muscle source' [patent_app_type] => B1 [patent_app_number] => 08/920439 [patent_app_country] => US [patent_app_date] => 1997-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7986 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451975.pdf [firstpage_image] =>[orig_patent_app_number] => 08920439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3915080 [patent_doc_number] => 06001965 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Anticancer compounds and methods' [patent_app_type] => 1 [patent_app_number] => 8/915189 [patent_app_country] => US [patent_app_date] => 1997-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 20245 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001965.pdf [firstpage_image] =>[orig_patent_app_number] => 915189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4034291 [patent_doc_number] => 05994502 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Inhibitors of oligosaccharyl transferase' [patent_app_type] => 1 [patent_app_number] => 8/914494 [patent_app_country] => US [patent_app_date] => 1997-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6583 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994502.pdf [firstpage_image] =>[orig_patent_app_number] => 914494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4146964 [patent_doc_number] => 06063758 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Substance P-Saporin (SP-SAP) conjugates and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/890157 [patent_app_country] => US [patent_app_date] => 1997-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 9905 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063758.pdf [firstpage_image] =>[orig_patent_app_number] => 890157 [rel_patent_id] =>[rel_patent_doc_number] =>)